阿片类抗体:临床效用,药理学,安全性和耐受性
Roger S McIntyre1, Marni E Harris2, Mark S Todtenkopf2
1Brain and Cognition Discovery Foundation (BCDF), University of Toronto, Toronto, ON, Canada.
CNS spectrums
|November 25, 2024
概括
阿片类抗体,FDA批准的药物,阻断阿片类受体用于各种疾病. 它们治疗成,逆转过量,控制体重,帮助胃肠道恢复,提供各种治疗益处.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 胃肠病学 胃肠病学
背景情况:
- 阿片类抗剂通过阻断阿片类受体而起作用.
- 这种机制支持它们在各种治疗领域的实用性.
- 了解它们的作用对于安全有效的使用至关重要.
研究的目的:
- 审查FDA批准的阿片类药物抗剂.
- 详细说明它们的作用点,临床用途,药理学和安全性.
- 阐明它们治疗效益的细微差别.
主要方法:
- 文献综述. 这是一个文献综述.
- 对FDA批准的阿片类药物抗剂产品标签的分析.
主要成果:
- 中心作用的抗剂治疗阿片类药物/酒精使用障碍并逆转过量.
- 组合产品可以控制体重并减轻抗精神病药物引起的体重增加.
- 周围作用的抗体治疗阿片类药物诱导的便秘,并加速术后的胃肠道恢复.
结论:
- 阿片类药物抗剂显示出基于药理学和作用部位的各种治疗益处.
- 它们通常被很好地容忍,没有依赖或滥用潜力.
- 风险包括迅速戒断和潜在的过量服用,如果阻塞被克服.
相关概念视频
Analgesia and Pain Management
513
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
513
Opioid Analgesics: Synthetic and Semisynthetic Opioids
225
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
225
Opioid Receptors: Overview
529
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
529
Opioid Analgesics: Morphine and Other Natural Cogeners
183
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
183
Drug-Receptor Interaction: Antagonist
2.7K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
2.7K
Drug-Receptor Interaction: Agonist
2.4K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.4K


